Chemotherapy with an every-2-week regimen of gemcitabine and paclitaxel in patients with transitional cell carcinoma who have received prior cisplatin-based therapy Academic Article uri icon

Overview

MeSH Major

  • Antineoplastic Combined Chemotherapy Protocols
  • Carcinoma, Transitional Cell
  • Deoxycytidine
  • Neoplasm Recurrence, Local
  • Urinary Bladder Neoplasms

abstract

  • The combination of gemcitabine and taxol in previously treated patients with recurrent TCC is highly effective and produces objective durable responses. This every-2-week schedule is a well tolerated outpatient regimen with minimal toxicity.

publication date

  • December 15, 2001

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1002/1097-0142(20011215)92:12<2993::AID-CNCR10108>3.0.CO;2-2

PubMed ID

  • 11753976

Additional Document Info

start page

  • 2993

end page

  • 8

volume

  • 92

number

  • 12